Pasithea Therapeutics Stock (NASDAQ: KTTA)
|Day Range- - -||52 Wk Range0.81 - 1.83||Open / Close- / -||Float / Outstanding24.5M / 26.7M|
|Vol / Avg.- / 488.4K||Mkt Cap33.4M||P/E-||50d Avg. Price1.21|
|Div / Yield-||Payout Ratio-||Total Float24.5M||EPS-0.11|
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Pasithea Therapeutics (NASDAQ: KTTA) through any online brokerage.
The latest price target for Pasithea Therapeutics (NASDAQ: KTTA) was reported by EF Hutton on Tuesday, December 14, 2021. The analyst firm set a price target for 3.25 expecting KTTA to rise to within 12 months (a possible 160.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Pasithea Therapeutics (NASDAQ: KTTA) is $1.25 last updated October 4, 2022, 8:00 PM UTC.
There are no upcoming dividends for Pasithea Therapeutics.
Pasithea Therapeutics’s Q3 earnings are confirmed for Thursday, November 17, 2022.
There is no upcoming split for Pasithea Therapeutics.
Pasithea Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.